FDA Wants More Data on Neffy, First Needle-Free Antidote for Severe Allergic Reactions

WEDNESDAY, Sept. 20, 2023 -- In a surprising move, the U.S. Food and Drug Administration (FDA) has opted not to approve a needle-free alternative to the EpiPen for emergency treatment of severe allergic reactions. Approval of the Neffy nasal spray...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news